NASDAQ · STOCK
Doximity
$20.90
52W $17.15 – $76.51
57/100
$3.91B
20.1
1.29
Is DOCS Bullish or Bearish?
Mixed.
Innellis AI committee rates Doximity (DOCS) Watch with a composite score of 57/100
, based on 7 analysts with 57% agreement.
Last updated August 01, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +3.11 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -16.89 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Risk Analyst sees a compelling case — low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. Growth Analyst remains cautious — eps declining -11.4% yoy despite any revenue growth. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 19.4% shows genuine earnings power backing the valuation — Value
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- Price-to-book of 4.5x prices in significant intangible value — Value
- EPS declining -11.4% YoY despite any revenue growth — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- Price structure making lower highs and lower lows — Technical
- MACD histogram negative -- bearish momentum — Technical
- Price structure (HH_HL) contradicts the downtrend -- mixed signals — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 01, 2026
Overall Committee Score
57/100
Agreement
57%
Analysts
7
Conviction
Contested
Sector Rank
Top 52%
of 93 Healthcare peers
Value Analyst
neutral
59
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 19.4% shows genuine earnings power backing the valuation
− Price-to-book of 4.5x prices in significant intangible value
Growth Analyst
bearish
40
/ 100 · High confidence
Growth story is weak, decelerating, or inconsistent
− EPS declining -11.4% YoY despite any revenue growth
Technical Analyst
neutral
47
/ 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement
− Price structure making lower highs and lower lows
Risk Analyst
bullish
80
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2535.03)
Investment Thesis Evolution
Committee score moved marginally from 54.5 to 56.9.
- Committee agreement fell notably from 71% to 57%.
- New bearish signals: 2 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance neutral->bullish; score 58->70 (+12).
- News Analyst: score 53->58 (+4).
- Portfolio Manager: +2 bearish signal(s).
Comparing 2026-07-31 to 2026-08-01 (1 day apart).
Technical Analysis
RSI (14)
43.2
Neutral
MACD Histogram
-0.050
Bearish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Hh Hl
Support
$20.57
Resistance
$26.68
Bollinger %B
0.27
Inside Bands
Price vs Moving Averages
EMA 9
$21.17
Below
EMA 21
$21.26
Below
EMA 50
$21.66
Below
EMA 200
$31.62
Below
Fundamental Analysis
Valuation
80
Growth
35
Profitability
1
Financial Health
100
Cash Flow
37
Valuation
P/E Ratio
20.1×
P/B Ratio
4.07×
PEG Ratio
-1.60
Dividend Yield
0.00%
52W High
$76.51
52W Low
$17.15
Quality & Growth
ROE
20.6%
ROA
17.4%
Gross Margin
89.1%
Operating Margin
33.3%
Revenue Growth YoY
—
Debt / Equity
0.01
AI Fundamental Assessment
P/E ratio of 20.1 (inexpensive relative to a 15-40x range); Price-to-book of 4.1x; PEG ratio of -1.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.2%; Return on assets of 0.2%; Net margin of 0.3%; Gross margin of 0.9%; Current ratio of 6.09 (healthy short-term liquidity); Debt-to-equity of 0.01; Free cash flow margin of 1.0% (thin cash generation); Free cash flow per share is positive (1.72); Most recent quarter missed estimates by 10.0%; EPS growth decelerating (+2.2% -> -43.5% QoQ); Analyst estimates falling over recent quarters
Get the Full DOCS Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →